Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Cytek Biosciences (CTKB) Return on Sales (2020 - 2025)

Cytek Biosciences (CTKB) has disclosed Return on Sales for 6 consecutive years, with 0.71% as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Return on Sales fell 88.0% year-over-year to 0.71%, compared with a TTM value of 0.33% through Dec 2025, down 30.0%, and an annual FY2025 reading of 0.33%, down 30.0% over the prior year.
  • Return on Sales was 0.71% for Q4 2025 at Cytek Biosciences, down from 0.1% in the prior quarter.
  • Across five years, Return on Sales topped out at 0.17% in Q4 2024 and bottomed at 0.71% in Q4 2025.
  • Average Return on Sales over 5 years is 0.08%, with a median of 0.05% recorded in 2021.
  • The sharpest move saw Return on Sales increased 15bps in 2024, then tumbled -88bps in 2025.
  • Year by year, Return on Sales stood at 0.03% in 2021, then surged by 357bps to 0.08% in 2022, then rose by 23bps to 0.09% in 2023, then soared by 77bps to 0.17% in 2024, then tumbled by -525bps to 0.71% in 2025.
  • Business Quant data shows Return on Sales for CTKB at 0.71% in Q4 2025, 0.1% in Q3 2025, and 0.12% in Q2 2025.